Cargando…
Mutations in SARS-CoV-2 are on the increase against the acquired immunity
Monovalent vaccines using mRNA or adenoviruses have provided substantial protection against the COVID-19 pandemic in many countries. However, viral mutations have hampered the efficacy of this approach. The Omicron variant, which appeared in Dec 2021, has caused a pandemic that has exerted pressure...
Autor principal: | Konishi, Tomokazu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273074/ https://www.ncbi.nlm.nih.gov/pubmed/35816505 http://dx.doi.org/10.1371/journal.pone.0271305 |
Ejemplares similares
-
SARS-CoV-2 mutations among minks show reduced lethality and infectivity to humans
por: Konishi, Tomokazu
Publicado: (2021) -
Continuous mutation of SARS-CoV-2 during migration via three routes at the beginning of the pandemic
por: Konishi, Tomokazu
Publicado: (2022) -
Cross protection to SARS-CoV-2 variants in hamsters with naturally-acquired immunity
por: Beitari, Saina, et al.
Publicado: (2023) -
Increased lethality in influenza and SARS-CoV-2 coinfection is prevented by influenza immunity but not SARS-CoV-2 immunity
por: Achdout, Hagit, et al.
Publicado: (2021) -
SARS-CoV-2 mutations acquired in mink reduce antibody-mediated neutralization
por: Hoffmann, Markus, et al.
Publicado: (2021)